Nature's biodiversity is the source of our innovation: microorganisms and their enzymes open up unique opportunities for us to develop sustainable and scalable solutions for tomorrow's markets.
We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.
We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.
30 August 2021, Zwingenberg (Germany) - Today, BRAIN Biotech AG (BRAIN, ISIN DE0005203947 / WKN 520394) published its results for the period from April 1st, 2021 to June 30th, 2021.
